DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR THE DETERMINATION OF ZALTOPROFEN IN BULK AND PHARMACEUTICAL TABLET DOSAGE FORM

Journal Title: Journal of Biomedical and Pharmaceutical Research - Year 2015, Vol 4, Issue 1

Abstract

A new RP-HPLC method was developed and validated for determination of Zaltoprofen in bulk and tablet dosage form. The estimation was carried out on Enable C18G (250 mm ×4.6 mm, 5 μm) column using Acetonitrile and Water in the ratio of 95:5 (v/v) as mobile phase. The flow rate was 1.0 ml/min and the effluent was monitored by UV detector at 331 nm. The retention time was 3.653 min and linearity was observed in the concentration range of 10-50 μg/ml. The percentage recovery was in good agreement with the labelled amount in the pharmaceutical formulation and the method was simple, precise and accurate for the determination of Zaltoprofen in bulk and pharmaceutical formulation.

Authors and Affiliations

Purnima Gandi*| Department of Pharmaceutical Analysis and Quality Assurance, Vignan Institue of Pharmaceutical Technology, Beside VSEZ, Duvvada, Visakhapatnam-530 049, Dr. Y. Srinivasa Rao| Department of Pharmaceutical Analysis and Quality Assurance, Vignan Institue of Pharmaceutical Technology, Beside VSEZ, Duvvada, Visakhapatnam-530 049, K. Vara Prasada Rao| Department of Pharmaceutical Analysis and Quality Assurance, Vignan Institue of Pharmaceutical Technology, Beside VSEZ, Duvvada, Visakhapatnam-530 049, T. Hemanth Kumar| Department of Pharmaceutical Analysis and Quality Assurance, Vignan Institue of Pharmaceutical Technology, Beside VSEZ, Duvvada, Visakhapatnam-530 049

Keywords

Related Articles

ASSESSMENT OF QTC INTERVAL: A CARDIOVASCULAR RISK FACTOR IN ASYMPTOMATIC TYPEII DIABETICS

Background and Objectives: Diabetes Mellitus (DM), metabolic disorder, characterized by hyperglycaemia. There are two main types of diabetes mellitus. Insulin dependent diabetes mellitus (type I DM), Non insulin depende...

PLATELET COUNT, PLATELET INDICES, ERYTHROCYTE SEDIMENTATION RATE AND C-REACTIVE PROTEIN IN PULMONARY TUBERCULOSIS PATIENTS IN ABU-ANJA HOSPITAL

Background: Tuberculosis (TB) is a major public health problem in Sudan. The pulmonary type is the most important form of tuberculosis, continues to be one of the most wide spread infectious diseases. The differential di...

SIGNIFICANCE OF PREFORMULATION STUDIES IN DESIGNING, FABRICATING FOR PHARMACEUTICAL DOSAGE FORMS

Prior to development of any formulations the physiochemical properties of drug should be known to the developer. Preformulation studies have a significant part to play in anticipating formulation problems and identifying...

COMPARITIVE EVALUATION OF TISSUE GLYCOGEN AND SALIVARY PH IN CHRONIC GINGIVITIS AND CHRONIC PERIODONTITIS PATIENTS

BACKGROUND: The inflammation of gingiva is known as gingivitis with microorganisms present in the gingival sulcus, being the major cause for this pathologic condition. Periodontitis is a chronic inflammatory disease whic...

HELLP SYNDROME: A BRIEF REVIEW

HELLP is an abbreviation of hemolysis (H), elevated liver enzyme (EL), and low platelet count (LP) which is a serious complication in pregnancy and also described as a severe form of preeclampsia and which is also associ...

Download PDF file
  • EP ID EP3491
  • DOI -
  • Views 349
  • Downloads 18

How To Cite

Purnima Gandi*, Dr. Y. Srinivasa Rao, K. Vara Prasada Rao, T. Hemanth Kumar (2015). DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR THE DETERMINATION OF ZALTOPROFEN IN BULK AND PHARMACEUTICAL TABLET DOSAGE FORM. Journal of Biomedical and Pharmaceutical Research, 4(1), 53-57. https://europub.co.uk/articles/-A-3491